Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence.

Journal: Reviews in cardiovascular medicine
Published Date: Dec 30, 2020

Abstract

Artificial Intelligence (AI), in general, refers to the machines (or computers) that mimic "cognitive" functions that we associate with our mind, such as "learning" and "solving problem". New biomarkers derived from medical imaging are being discovered and are then fused with non-imaging biomarkers (such as office, laboratory, physiological, genetic, epidemiological, and clinical-based biomarkers) in a big data framework, to develop AI systems. These systems can support risk prediction and monitoring. This perspective narrative shows the powerful methods of AI for tracking cardiovascular risks. We conclude that AI could potentially become an integral part of the COVID-19 disease management system. Countries, large and small, should join hands with the WHO in building biobanks for scientists around the world to build AI-based platforms for tracking the cardiovascular risk assessment during COVID-19 times and long-term follow-up of the survivors.

Authors

  • Jasjit S Suri
    Advanced Knowledge Engineering Center, Global Biomedical Technologies, Inc., Roseville, CA, USA. Electronic address: jsuri@comcast.net.
  • Anudeep Puvvula
    Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA.
  • Misha Majhail
    Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA.
  • Mainak Biswas
    Department of Computer Science and Engineering, NIT, Goa, India.
  • Ankush D Jamthikar
    Department of Electronics and Communication Engineering, Visvesvaraya National Institute of Technology, Nagpur, Maharashtra, India.
  • Luca Saba
    Department of Radiology, A.O.U., Italy.
  • Gavino Faa
    Department of Pathology, 09100, AOU of Cagliari, Italy.
  • Inder M Singh
    Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA.
  • Ronald Oberleitner
    Behavior Imaging, Boise, 83701, ID, USA.
  • Monika Turk
    Department of Neurology, University Medical Centre Maribor, Slovenia.
  • Saurabh Srivastava
    2Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, UP India.
  • Paramjit S Chadha
    Stroke Monitoring and Diagnostic Division, AtheroPoint™, Roseville, 95747, CA, USA.
  • Harman S Suri
    Brown University, Providence, RI, USA; Monitoring and Diagnostic Division, AtheroPoint™, Roseville, CA, USA.
  • Amer M Johri
    Division of Cardiology, Department of Medicine, Queen's University, Kingston, ON, Canada.
  • Vijay Nambi
    Department of Cardiology, Baylor College of Medicine, 77001, TX, USA.
  • J Miguel Sanches
    Bioengineering Department, IST, University of Lisbon, Portugal.
  • Narendra N Khanna
    Cardiology Department, Apollo Hospitals, New Delhi, India.
  • Klaudija Viskovic
    University Hospital for Infectious Diseases, 10000, Zagreb, Crotia.
  • Sophie Mavrogeni
    Cardiology Clinic, Onassis Cardiac Surgery Center, Athens, Greece.
  • John R Laird
    UC Davis Vascular Center, University of California, Davis, CA, USA.
  • Arindam Bit
    Department of Biomedical Engineering, National Institute of Technology, Raipur, India.
  • Gyan Pareek
    Minimally Invasive Urology Institute, Brown University, Providence, 02901, Rhode Island, USA.
  • Martin Miner
    Men's Health Center, Miriam Hospital Providence, 02901, Rhode Island, USA.
  • Antonella Balestrieri
    Department of Radiology, A.O.U., Italy.
  • Petros P Sfikakis
    1st Department of Propaedeutic Internal Medicine, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
  • George Tsoulfas
    Aristoteleion University of Thessaloniki, 544 53, Thessaloniki, Greece.
  • Athanasios Protogerou
    Department of Cardiovascular Prevention & Research Unit Clinic & Laboratory of Pathophysiology, National and Kapodistrian Univ. of Athens, Greece.
  • Durga Prasanna Misra
    Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226001, UP, India.
  • Vikas Agarwal
    Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
  • George D Kitas
    Arthritis Research UK Centre for Epidemiology, Manchester University, Manchester, UK.
  • Raghu Kolluri
    OhioHealth Heart and Vascular, 45874, Ohio, USA.
  • Jagjit Teji
    Ann and Robert H. Lurie Children's Hospital of Chicago, 60601, Chicago, USA.
  • Michele Porcu
    Azienda Ospedaliero Universitaria (A.O.U.) di Cagliari - Polo di Monserrato; Università di Cagliari, S.S. 554, Monserrato, Cagliari, 09045, Italy. Electronic address: micheleporcu87@gmail.com.
  • Mustafa Al-Maini
    Allergy, Clinical Immunology and Rheumatology Institute, M3H 6A7, Toronto, Canada.
  • Ann Agbakoba
    University of Lagos, 100001, Lagos, Nigeria.
  • Meyypan Sockalingam
    MV Center of Diabetes, 600001, Chennai, India.
  • Ajit Sexena
    Department of Cardiology, Indraprastha APOLLO Hospitals, 110001, New Delhi, India.
  • Andrew Nicolaides
    Vascular Screening and Diagnostic Centre, London, England, United Kingdom; Vascular Diagnostic Center, University of Cyprus, Nicosia, Cyprus.
  • Aditya Sharma
    Division of Cardiovascular Medicine, University of Virginia, Charlottesville, 22901, VA, USA.
  • Vijay Rathore
    Nephrology Department, Kaiser Permanente, Sacramento, 94203, CA, USA.
  • Vijay Viswanathan
    MV Hospital for Diabetes and Professor M Viswanathan Diabetes Research Centre, Chennai, India.
  • Subbaram Naidu
    Electrical Engineering Department, University of Minnesota, Duluth, 55801, MN, USA.
  • Deepak L Bhatt
    Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts.

Keywords

External Resources

Popular Topics
Recent Journals